Author

Vanessa Gourhand

Inserm

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Karl BalabanianiD· 2 shared Marion EspéliiD· 2 shared Amélie BonaudiD· 1 shared Camilla JandusiD· 1 shared Clémentine MouliniD· 1 shared Daniel A. BenamraniD· 1 shared Emilie LereclusiD· 1 shared Emma DespondsiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Karl BalabanianORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintMar 21, 2025

Targeting CXCR4-expressing TAMs in muscle-invasive bladder cancer to enhance tumor control after immunotherapy

Emma Desponds, Hajar El Ahanidi, Nagham Alouche…·Grégory Verdeil

This study identifies CXCR4-expressing tumor-associated macrophages in bladder cancer and shows that targeting them improves immunotherapy outcomes in mice and patients.

DOI 10.1101/2025.03.21.644543

mousehuman

𝕏 PostBluesky

ImmunologybioRxivPreprintMar 26, 2024

Plasma cell heterogeneity is driven by type of immune challenge

Mélanie Khamyath, Emilie Lereclus, Vanessa Gourhand…·Amélie Bonaud

This study identifies five plasma cell subsets in humans and mice, showing their heterogeneity is driven by immune challenge type and B cell origin.

1 citation

humanmouse

𝕏 PostBluesky